HIV mutation literature information.


  Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals.
 PMID: 33173092       2020       Scientific reports
Result: These results indicate that the HLA-B*51:01-adapted Y120F/Q125H mutations selectively impaired Nef's ability to counteract SERINC3/5 but that CD4, CCR5, CXCR4 and HLA downregulation functions and CD74 upregulation function remained unaffected.
Discussion: The highly conserved D123 residue (> 99% prevalence in subtype A, B, C and D) is encompassed by the immune-escape mutation sites of Y120F and Discussion: We have demonstrated here that a number of naturally-occurring Nef variants (Y120F and Q125H) associated with a certain HLA class I allele (HLA-B*51:01) inversely correlated with the plasma viral load in treatment-naive HIV-infected patients harboring this HLA allele.



Browser Board

 Co-occurred Entities




   Filtrator